ADC Therapeutics SA (ADCT) Financials
ADCT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 354.8 million | 503.0 million |
2023-09-30 | 466.9 million | 521.1 million |
2023-06-30 | 507.3 million | 515.9 million |
2023-03-31 | 467.7 million | 430.0 million |
ADCT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -33.4 million | 1.6 million |
2023-09-30 | -34.7 million | 2.5 million |
2023-06-30 | -38.0 million | 1.1 million |
2023-03-31 | -15.8 million | 8.3 million |
ADCT Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | -85.7 million |
2023-09-30 | -47.8 million |
2023-06-30 | -47.1 million |
2023-03-31 | -59.4 million |
ADCT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 278.6 million | - | 11.6 million |
2023-09-30 | 310.4 million | - | 11.5 million |
2023-06-30 | 347.5 million | - | 12.4 million |
2023-03-31 | 310.5 million | - | 12.4 million |
ADCT Shares Outstanding
ADCT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 327000 | 30.3 million | 17.2 million | 9.3 million |
2023-09-30 | 661000 | 28.4 million | 15.1 million | 8.0 million |
2023-06-30 | 1.2 million | 31.9 million | 12.6 million | 8.3 million |
2023-03-31 | 1.0 million | 39.5 million | 15.1 million | 15.4 million |
ADCT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 16.8 million | 1.2 million |
2023-09-30 | 14.5 million | 366000 |
2023-06-30 | 19.3 million | 1.3 million |
2023-03-31 | 19.0 million | 590000 |
ADCT
Price: $4.90
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -1.65
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Market Capitalization: 412.6 million